GW5074 and Dexamethasone Reduce Airway Hyperresponsiveness in Mice Exposed to Sidestream Smoke
Author Information
Author(s): Lei Ying, Cao Yong-Xiao, Xu Cang-Bao, Zhang Yaping
Primary Institution: Xi'an Jiaotong University College of Medicine
Hypothesis
Can the Raf-1 inhibitor GW5074 and the anti-inflammatory drug dexamethasone suppress airway hyperreactivity in a mouse model of sidestream smoke exposure?
Conclusion
Both GW5074 and dexamethasone effectively suppress airway hyperresponsiveness and inflammation caused by sidestream smoke in mice.
Supporting Evidence
- Sidestream smoke exposure increased airway contractile response in mice.
- GW5074 and dexamethasone significantly suppressed enhanced airway contractile responses.
- Inflammatory cell infiltration and mucous gland hypertrophy were reduced by both treatments.
Takeaway
This study shows that two drugs can help mice breathe better after being exposed to smoke from cigarettes.
Methodology
Mice were exposed to sidestream smoke and treated with GW5074 or dexamethasone, followed by assessment of airway responsiveness and inflammation.
Limitations
The study was conducted in mice, which may not fully replicate human responses.
Participant Demographics
Six-week-old male ICR mice
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website